C-MER MEDICAL (03309) chairman, Lin Shun-Chiu, increased his holding by 1.174 million shares of the company's stock.

C-MER MEDICAL (03309) announced that as of September 12, 2024, the Chairman, CEO, and Executive Director, Lin Shunchao, has purchased a total of 1.174 million shares of the company's stock on the market, at a total cost of approximately HK$2.4029 million, equivalent to an average price of approximately HK$2.05 per share. Prior to the purchase from September 12 to September 17, Lin Shunchao, together with Xima Group Limited (the controlling shareholder of the company, owned by Lin Shunchao 70% and by his spouse and director of the company, Li Xiaoting, 30%) held approximately 55.00% of the company's issued share capital. Following the purchase from September 12 to September 17, Lin Shunchao, together with Xima Group Limited, currently holds approximately 55.10% of the company's issued shares.